UnitedHealth now has to fight the government on another front. The stock is sinking. - MarketWatch
1. DOJ launches civil probe into UNH Medicare billing practices. Regulatory risk rises. 2. Regulators block UNH’s $3.3B Amedisys deal. Merger faces uncertainty. 3. UNH stock fell 11.3% in premarket trading. Investor sentiment is sharply negative. 4. Controversies over coverage denials and high drug costs persist. Public backlash intensifies.